{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:32:04Z","timestamp":1761895924663},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["patient-research.elsevier.com","ajconline.org","mdconsult.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.amjcard.2014.07.030","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T02:46:28Z","timestamp":1406688388000},"page":"1145-1150","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of Baseline Coronary Occlusion and Diabetes Mellitus in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"114","author":[{"given":"Raffaele","family":"Piccolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Galasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan Zeeberg","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Eitel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Dominguez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlan L.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart J.G.L.","family":"de Smet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim D.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Abreu-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Trimarco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Piscione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2014.07.030_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2014.07.030_bib2","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.2337\/dc11-2462","article-title":"Short- and long-term mortality after myocardial infarction in patients with and without diabetes: changes from 1985 to 2008","volume":"35","author":"Nauta","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2014.07.030_bib3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0735-1097(92)90033-J","article-title":"Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis","volume":"20","author":"Jacoby","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.07.030_bib4","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0735-1097(96)00397-X","article-title":"Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience","volume":"28","author":"Woodfield","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.07.030_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9149(99)00598-6","article-title":"Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction","volume":"85","author":"Brodie","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.07.030_bib6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/hc3101.093701","article-title":"Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the Primary Angioplasty in Myocardial Infarction trials","volume":"104","author":"Stone","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.07.030_bib7","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/hrt.2008.160390","article-title":"Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?","volume":"95","author":"Bainey","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2014.07.030_bib8","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.4244\/EIJV9I9A186","volume":"9","author":"Piccolo","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2014.07.030_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.atherosclerosis.2009.03.011","article-title":"Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention\u2013effects on soluble cd40 ligand concentrations","volume":"206","author":"Dominguez-Rodriguez","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2014.07.030_bib10","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1161\/CIRCULATIONAHA.110.002741","volume":"122","author":"Gu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.07.030_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1540-8183.2010.00616.x","article-title":"Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial","volume":"24","author":"Iversen","year":"2011","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.amjcard.2014.07.030_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.107.747642","volume":"118","author":"Thiele","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.07.030_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(11)61872-2","article-title":"Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial","volume":"379","author":"Thiele","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2014.07.030_bib14","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2014.07.030_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10654-005-7835-x","article-title":"Calculating measures of biological interaction","volume":"20","author":"Andersson","year":"2005","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.amjcard.2014.07.030_bib16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.amjcard.2011.11.046","article-title":"Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute st-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI)","volume":"109","author":"Brener","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2014.07.030_bib17","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/CIRCIMAGING.112.974998","article-title":"Prognostic impact of hyperglycemia in nondiabetic and diabetic patients with ST-elevation myocardial infarction: insights from contrast-enhanced magnetic resonance imaging","volume":"5","author":"Eitel","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2014.07.030_bib18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ccd.25203","article-title":"Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: results from the INFUSE-AMI study","volume":"83","author":"Sanidas","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2014.07.030_bib19","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4244\/EIJV8I11A199","article-title":"Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial","volume":"8","author":"Rakowski","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2014.07.030_bib20","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jacc.2003.11.042","article-title":"Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty","volume":"43","author":"De Luca","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.07.030_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacc.2008.05.009","article-title":"Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes","volume":"52","author":"Ndrepepa","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2014.07.030_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(06)68148-8","article-title":"Comparison of primary and facilitated percutaneous coronary interventions for st-elevation myocardial infarction: quantitative review of randomised trials","volume":"367","author":"Keeley","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2014.07.030_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.atherosclerosis.2012.04.018","article-title":"Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER registry)","volume":"223","author":"Dziewierz","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2014.07.030_bib24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4244\/EIJV6I3A56","article-title":"Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-TIME 2 trial","volume":"6","author":"Timmer","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2014.07.030_bib25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/0003319712467530","article-title":"Pharmacotherapeutic considerations for the use of prasugrel and ticagrelor to reduce stent thrombosis in patients with acute coronary syndrome","volume":"65","author":"Piccolo","year":"2014","journal-title":"Angiology"},{"key":"10.1016\/j.amjcard.2014.07.030_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ahj.2012.12.015","volume":"165","author":"Montalescot","year":"2013","journal-title":"Am Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491401491X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491401491X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T08:50:31Z","timestamp":1538383831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291491401491X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S000291491401491X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2014.07.030","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Baseline Coronary Occlusion and Diabetes Mellitus in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2014.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}